20 (AIDX) Cash from Investing Activities (2026)
20 (AIDX) posted Cash from Investing Activities of -$5354.0 for Q1 2026.
20 (AIDX) Cash from Investing Activities (2026) Analysis & Trends
20's Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$5354.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | -475.32 Mn |
| 10 | 20 | 3.45 Mn | -772,580.19 | 62,884.00 | -5,354.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,354.00 |
| Mar 31, 2026 | -5,354.00 |